These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 28296584)

  • 1. Intestinal Microbiota and Relapse After Hematopoietic-Cell Transplantation.
    Peled JU; Devlin SM; Staffas A; Lumish M; Khanin R; Littmann ER; Ling L; Kosuri S; Maloy M; Slingerland JB; Ahr KF; Porosnicu Rodriguez KA; Shono Y; Slingerland AE; Docampo MD; Sung AD; Weber D; Alousi AM; Gyurkocza B; Ponce DM; Barker JN; Perales MA; Giralt SA; Taur Y; Pamer EG; Jenq RR; van den Brink MRM
    J Clin Oncol; 2017 May; 35(15):1650-1659. PubMed ID: 28296584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of intestinal microbiota in antithymocyte globulin-based myeloablative allogeneic hematopoietic cell transplantation.
    Gu Z; Xiong Q; Wang L; Wang L; Li F; Hou C; Dou L; Zhu B; Liu D
    Cancer; 2022 Apr; 128(7):1402-1410. PubMed ID: 35077579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of Gut Microbiota Composition and Diversity in Acute and/or Chronic Graft-versus-Host Disease Following Hematopoietic Stem Cell Transplantation: A Prospective Cohort Study.
    Gavriilaki E; Christoforidi M; Ouranos K; Minti F; Mallouri D; Varelas C; Lazaridou A; Baldoumi E; Panteliadou A; Bousiou Z; Batsis I; Sakellari I; Gioula G
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stool Microbiota at Neutrophil Recovery Is Predictive for Severe Acute Graft vs Host Disease After Hematopoietic Cell Transplantation.
    Golob JL; Pergam SA; Srinivasan S; Fiedler TL; Liu C; Garcia K; Mielcarek M; Ko D; Aker S; Marquis S; Loeffelholz T; Plantinga A; Wu MC; Celustka K; Morrison A; Woodfield M; Fredricks DN
    Clin Infect Dis; 2017 Nov; 65(12):1984-1991. PubMed ID: 29020185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preservation of the fecal microbiome is associated with reduced severity of graft-versus-host disease.
    Burgos da Silva M; Ponce DM; Dai A; M Devlin S; Gomes ALC; Moore G; Slingerland J; Shouval R; Armijo GK; DeWolf S; Fei T; Clurman A; Fontana E; Amoretti LA; Wright RJ; Andrlova H; Miltiadous O; Perales MA; Taur Y; Peled JU; van den Brink MRM
    Blood; 2022 Dec; 140(22):2385-2397. PubMed ID: 35969834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiota Predict Infections and Acute Graft-Versus-Host Disease After Pediatric Allogeneic Hematopoietic Stem Cell Transplantation.
    Margolis EB; Alfaro GM; Sun Y; Dallas RH; Allison KJ; Ferrolino J; Ross HS; Davis AE; Jia Q; Turner P; Mackay V; Morin CE; Triplett BM; Klein EJ; Englund JA; Tang L; Hayden RT
    J Infect Dis; 2023 Aug; 228(5):627-636. PubMed ID: 37249910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the intestinal microbiota in allogeneic HCT: clinical associations and preclinical mechanisms.
    Nguyen CL; Docampo MD; van den Brink MR; Markey KA
    Curr Opin Genet Dev; 2021 Feb; 66():25-35. PubMed ID: 33388483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The intestinal microbiota in allogeneic hematopoietic cell transplant and graft-versus-host disease.
    Staffas A; Burgos da Silva M; van den Brink MR
    Blood; 2017 Feb; 129(8):927-933. PubMed ID: 27940475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal Microbiota Influence Immune Tolerance Post Allogeneic Hematopoietic Cell Transplantation and Intestinal GVHD.
    Köhler N; Zeiser R
    Front Immunol; 2018; 9():3179. PubMed ID: 30705680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival of Lymphoma Patients Experiencing Relapse or Progression after an Allogeneic Hematopoietic Cell Transplantation.
    Epperla N; Hamadani M; Ahn KW; He F; Kodali D; Kleman A; Hari PN; Pasquini M; Fenske TS; Craig MD; Kanate AS; Bachanova V
    Biol Blood Marrow Transplant; 2018 May; 24(5):983-988. PubMed ID: 29410340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical impact of pre-transplant gut microbial diversity on outcomes of allogeneic hematopoietic stem cell transplantation.
    Doki N; Suyama M; Sasajima S; Ota J; Igarashi A; Mimura I; Morita H; Fujioka Y; Sugiyama D; Nishikawa H; Shimazu Y; Suda W; Takeshita K; Atarashi K; Hattori M; Sato E; Watakabe-Inamoto K; Yoshioka K; Najima Y; Kobayashi T; Kakihana K; Takahashi N; Sakamaki H; Honda K; Ohashi K
    Ann Hematol; 2017 Sep; 96(9):1517-1523. PubMed ID: 28733895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic and Clinical Burden of Virus-Associated Hemorrhagic Cystitis in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation in the United States.
    McGuirk J; Divine C; Moon SH; Chandak A; Zhang Z; Papanicolaou GA
    Transplant Cell Ther; 2021 Jun; 27(6):505.e1-505.e9. PubMed ID: 33775616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing Treatment-Related Mortality Did Not Improve Outcomes of Allogeneic Myeloablative Hematopoietic Cell Transplantation for High-Risk Multiple Myeloma: A University of Michigan Prospective Series.
    Pawarode A; Mineishi S; Reddy P; Braun TM; Khaled YA; Choi SW; Magenau JM; Harris AC; Connelly JA; Kitko CL; Parkin BL; Goldstein SC; Yanik GA; Levine JE; Ferrara JL; Couriel DR
    Biol Blood Marrow Transplant; 2016 Jan; 22(1):54-60. PubMed ID: 26211984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiome: An Emerging New Frontier in Graft-Versus-Host Disease.
    Kumari R; Palaniyandi S; Hildebrandt GC
    Dig Dis Sci; 2019 Mar; 64(3):669-677. PubMed ID: 30523482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Impact of Disease Risk and Post Allograft Minimal Residual Disease on Survival.
    Dhakal B; D'Souza A; Martens M; Kapke J; Harrington AM; Pasquini M; Saber W; Drobyski WR; Zhang MJ; Hamadani M; Hari PN
    Clin Lymphoma Myeloma Leuk; 2016 Jul; 16(7):379-86. PubMed ID: 27160644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice.
    Shono Y; Docampo MD; Peled JU; Perobelli SM; Velardi E; Tsai JJ; Slingerland AE; Smith OM; Young LF; Gupta J; Lieberman SR; Jay HV; Ahr KF; Porosnicu Rodriguez KA; Xu K; Calarfiore M; Poeck H; Caballero S; Devlin SM; Rapaport F; Dudakov JA; Hanash AM; Gyurkocza B; Murphy GF; Gomes C; Liu C; Moss EL; Falconer SB; Bhatt AS; Taur Y; Pamer EG; van den Brink MRM; Jenq RR
    Sci Transl Med; 2016 May; 8(339):339ra71. PubMed ID: 27194729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity.
    DeFilipp Z; Peled JU; Li S; Mahabamunuge J; Dagher Z; Slingerland AE; Del Rio C; Valles B; Kempner ME; Smith M; Brown J; Dey BR; El-Jawahri A; McAfee SL; Spitzer TR; Ballen KK; Sung AD; Dalton TE; Messina JA; Dettmer K; Liebisch G; Oefner P; Taur Y; Pamer EG; Holler E; Mansour MK; van den Brink MRM; Hohmann E; Jenq RR; Chen YB
    Blood Adv; 2018 Apr; 2(7):745-753. PubMed ID: 29592876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contribution of the intestinal microbiome to immune recovery after HCT.
    Wolfe AE; Markey KA
    Front Immunol; 2022; 13():988121. PubMed ID: 36059482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.